GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » Price-to-Owner-Earnings

Sopharma Trading AD (XBUL:SFT) Price-to-Owner-Earnings : 6.32 (As of May. 01, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD Price-to-Owner-Earnings?

As of today (2024-05-01), Sopharma Trading AD's share price is лв5.75. Sopharma Trading AD's Owner Earnings per Share (TTM) ended in Sep. 2023 was лв0.91. It's Price-to-Owner-Earnings for today is 6.32.


The historical rank and industry rank for Sopharma Trading AD's Price-to-Owner-Earnings or its related term are showing as below:

XBUL:SFT' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 4.6   Med: 11.26   Max: 280
Current: 6.21

During the past 13 years, the highest Price-to-Owner-Earnings of Sopharma Trading AD was 280.00. The lowest was 4.60. And the median was 11.26.


XBUL:SFT's Price-to-Owner-Earnings is ranked better than
79.59% of 49 companies
in the Medical Distribution industry
Industry Median: 14.11 vs XBUL:SFT: 6.21

As of today (2024-05-01), Sopharma Trading AD's share price is лв5.75. Sopharma Trading AD's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was лв0.26. Therefore, Sopharma Trading AD's PE Ratio for today is 22.03.

As of today (2024-05-01), Sopharma Trading AD's share price is лв5.75. Sopharma Trading AD's EPS without NRI for the trailing twelve months (TTM) ended in was лв0.83. Therefore, Sopharma Trading AD's PE Ratio without NRI for today is 6.89.

During the past 13 years, Sopharma Trading AD's highest PE Ratio without NRI was 57.64. The lowest was 5.15. And the median was 16.29.


Sopharma Trading AD Price-to-Owner-Earnings Historical Data

The historical data trend for Sopharma Trading AD's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD Price-to-Owner-Earnings Chart

Sopharma Trading AD Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.33 13.92 9.07 7.01 7.28

Sopharma Trading AD Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.96 7.28 6.87 6.29 6.70

Competitive Comparison of Sopharma Trading AD's Price-to-Owner-Earnings

For the Medical Distribution subindustry, Sopharma Trading AD's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma Trading AD's Price-to-Owner-Earnings Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Sopharma Trading AD's Price-to-Owner-Earnings falls into.



Sopharma Trading AD Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Sopharma Trading AD's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=5.75/0.91
=6.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sopharma Trading AD  (XBUL:SFT) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Sopharma Trading AD Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma Trading AD (XBUL:SFT) Business Description

Traded in Other Exchanges
N/A
Address
Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD (XBUL:SFT) Headlines

No Headlines